| Reagent | Target | Concentration | Duration | Usage | Source |
| AMD3100 | CXCR4 | 5 μg/ml | 30 min | Pre-treat MSCs | Sigma-Aldrich, St. Louis, MO, USA | AZD0530 | Src | 10 μM | 24 h | Pre-treat MSCs | Selleck Chemicals, Houston, TX, USA | MK-2206 | Akt1/2/3 | 10 μM | 24 h | Pre-treat MSCs | Selleck Chemicals, Houston, TX, USA | U0126 | MEK1/2 | 50 μM | 24 h | Pre-treat MSCs | Selleck Chemicals, Houston, TX, USA | SP600125 | JNK1/2/3 | 10 μM | 24 h | Pre-treat MSCs | Selleck Chemicals, Houston, TX, USA | SB203580 | p38 MAPK | 1 μM | 30 min | Pre-treat MSCs | Selleck Chemicals, Houston, TX, USA | JNJ-10198409 | PDGFRβ | 5 μM | 1 h | Pre-treat MSCs | MedChemExpress, Monmouth Junction, NJ, USA | SU5408 | VEGFR2 | 5 μM | 1/2d since implantation | Intraperitoneal injection | MedChemExpress, Monmouth Junction, NJ, USA |
|
|